Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Organigram Global ( (TSE:OGI) ) just unveiled an update.
On February 18, 2026, Organigram Global announced a definitive agreement to acquire all remaining shares of German-based Sanity Group GmbH, in a transaction valuing upfront consideration at €113.4 million plus up to €113.8 million in earnouts tied to Sanity’s first-year post-closing performance. The deal combines cash and Organigram equity priced at a substantial premium to its prior TSX close and is designed to cement Organigram’s presence in Germany, the world’s second-largest federally legal cannabis market, while broadening exposure across Europe.
To fund the acquisition, Organigram secured a commitment for up to $60 million in senior secured credit facilities from ATB Financial and arranged a concurrent private placement with British American Tobacco’s subsidiary for gross proceeds of about C$65.2 million. Because BAT is an insider and the transaction and financing are considered related-party deals that could significantly increase BAT’s ownership and overall share issuance, they require disinterested shareholder approval, with closing targeted for the second quarter of 2026 and expected to strengthen Organigram’s global scale and financing flexibility.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Organigram Global stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is held back primarily by weak operating profitability and negative cash flow despite revenue growth, reinforced by bearish technicals (below key moving averages and negative MACD). A low-leverage balance sheet and a moderate P/E provide partial support but are not enough to offset the core earnings and cash-flow risks.
To see Spark’s full report on TSE:OGI stock, click here.
More about Organigram Global
Organigram Global Inc. is a Canadian cannabis producer listed on NASDAQ and the TSX, focused on medical and adult-use cannabis products. The company is expanding its international footprint, targeting major federally legal markets such as Germany and other European jurisdictions including the U.K., Switzerland and Poland.
Average Trading Volume: 364,705
Technical Sentiment Signal: Sell
Current Market Cap: C$263.5M
Learn more about OGI stock on TipRanks’ Stock Analysis page.